
Ascendis Pharma (ASND)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Ascendis Pharma (ASND) Stock
Start investing in Ascendis Pharma (ASND)
About Ascendis Pharma (ASND)
Market cap | $10.31B |
Today's volume | 29.32K |
Revenue (TTM) | $394.05M |
Avg. daily volume | 500.88K |
EBITDA (TTM) | -$339.92M |
Open | $170.66 |
Price / earnings ratio | -27.14x |
Today's range | $170.66 - $174.16 |
Debt / equity | — |
52 week range | $111.09 - $183 |
5 year debt / equity | -113.1x |
Beta (LTM) | 0.58x |
Interest coverage | -4.26x |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 1.04x |
Ex-dividend date | — |
Next earnings | Sep 2, 2025 |
Dividend payable date | — |
Ascendis Pharma Stock Rating
Ascendis Pharma Stock News
View all



Frequently Asked Questions (FAQ)
How to buy ASND stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in ASND stock
Navigate to the Explore page. Then, type ASND into the search bar. When you see ASND stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased ASND stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Ascendis Pharma Stock Earnings
The value each ASND share was expected to gain vs. the value that each ASND share actually gained.
Ascendis Pharma (ASND) reported Q1 2025 earnings per share (EPS) of -$1.66, missing estimates of -$1.51 by 9.93%. In the same quarter last year, Ascendis Pharma's earnings per share (EPS) was -$2.50. Ascendis Pharma is expected to release next earnings on 09/02/2025, with an earnings per share (EPS) estimate of $0.